Free tool
FAERS Monitor: Ultratag
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 019981 or its brand name (Ultratag, Technetium Tc-99m Red Blood Cell Kit). Reports on generic versions are filed under their own applications.
Reports
112
Serious
4
4% of reports
Hospitalization
0
Death reported
3
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug ineffective75
- radioisotope scan abnormal15
- pruritus7
- urticaria6
- multiple gated acquisition scan abnormal5
- radiation overdose5
- dizziness3
- drug monitoring procedure not performed3
- dyspnoea3
- erythema3
- flushing3
- lip swelling3
- extravasation2
- nausea2
- pallor2
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2008 | 13 |
| 2009 | 15 |
| 2010 | 15 |
| 2011 | 11 |
| 2012 | 8 |
| 2013 | 6 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2018 | 8 |
| 2019 | 4 |
| 2020 | 2 |
| 2021 | 21 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,047 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| multiple gated acquisition scan abnormalSignal | 5 | 24734.5 | 9918.0 | 88,519 |
| radiation overdoseSignal | 5 | 19181.9 | 7788.3 | 70,485 |
| radioisotope scan abnormalSignal | 15 | 4074.8 | 2529.4 | 55,876 |
| drug monitoring procedure not performedSignal | 3 | 314.2 | 102.8 | 649 |
| extravasation | 2 | 91.4 | 23.1 | 100 |
| lip swellingSignal | 3 | 16.9 | 5.5 | 30 |
| pallor | 2 | 13.8 | 3.5 | 13 |
| drug ineffectiveSignal | 75 | 10.7 | 9.4 | 692 |
| urticariaSignal | 6 | 6.7 | 3.1 | 24 |
| flushingSignal | 3 | 5.5 | 1.8 | 7 |
| pruritusSignal | 7 | 3.4 | 1.7 | 10 |
| erythema | 3 | 2.7 | 0.9 | 2 |
| dizziness | 3 | 1.1 | 0.4 | 0 |
| dyspnoea | 3 | 1.0 | 0.3 | 0 |
| nausea | 2 | 0.5 | 0.1 | 1 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.